CD19 and acute lymphoblastic leukemia: It has been demonstrated that CD19-negative leukemic cells were present before the infusion of CAR T-cells in patients with CD19-negative B-ALL relapse after CAR T-cell therapy using single-cell RNA sequencing [59].